A drug that was developed to treat pancreatic cancer has now been shown to increase symptom-free survival in preclinical medulloblastoma models – all without showing signs of toxicity. Medulloblastoma is the most common malignant brain tumor in children. Survival rates vary according to which one of the four subtypes...

Drug developed for pancreatic cancer shows promise against most aggressive form of medulloblastoma

Cancer cells can hijack cell cycles to exponentially increase their numbers, a process called proliferation. Cancer drugs can stop the growth of cancer cells by jumpstarting a complex chain of genetic and cellular events. But often, this story is more complex, involving treatments that don’t work as well as had been hoped.

How Do Cancer Cells Divide Despite Treatment?

Researchers have discovered a new pathway used by cancer cells to infiltrate the brain and developed a promising therapy that targets this pathway with CAR T cells. Their study showed significant preclinical success in increasing survival and eradicating tumors in animal models of glioblastoma and other brain cancers. A team...

Brain Cancer Breakthrough: New Therapy Destroys Glioblastoma in Recently Unveiled Pathway

Researchers from Harvard Medical School and the Dana-Farber Cancer Institute have figured out how to give a timely boost to a revolutionary treatment that enlists immune cells in the anticancer fight, potentially bypassing a flaw that allows the therapy to fade before all diseased cells are gone. The researchers, Mohammad...

Fixing key flaw in revolutionary cancer treatment

Cancer vaccines may pair well with other forms of immunotherapy in the treatment of patients with cancer, according to Catherine J. Wu, MD. In a conversation with CancerNetwork®, Catherine J. Wu, MD, spoke about the ongoing development of cancer vaccines as a potentially “cross-cutting” therapeutic strategy for treating patients with cancer.

Taking a “Cross-Cutting Approach” With Cancer Vaccinations

The US Sun

A SINGLE-dose nasal spray treatment could 'wash away' build ups of toxic proteins associated with Alzheimer’s disease from brain cells and improve memory, scientists say. The study - performed on mice - paves the way for new treatments against Alzheimer's and dementia, researchers at the University of Texas Medical Branch said.

Single-dose nasal spray ‘washes the brain’ of toxic Alzheimer’s proteins – paving the way for breakthrough treatment

OAK BROOK, Ill. – An alarming new study finds that many non-smokers are carrying some concerning growths in their lungs, putting their future health at risk. Researchers from the Netherlands have discovered that small growths in the lungs, known as lung nodules, are surprisingly common even among people who have never picked up a cigarette in their lives.

Scientists make concerning discovery in the lungs of many non-smokers

We asked oncology experts what questions patients should ask their doctors soon after receiving a cancer diagnosis. This is their advice. Receiving a cancer diagnosis can be shocking, overwhelming and comes with a ton of new information — from disease types and stages to new drug names and treatment types. Patients and their loved ones may have a list of questions running through their minds, or they may not know what to ask.

Questions Patients Should Ask After a Cancer Diagnosis

Researchers have demonstrated that adding metastasis-directed radiation therapy to standard-of-care chemotherapy may improve progression-free survival in patients with oligometastatic pancreatic cancer, according to a recent study published by Ludmir et al in the Journal of Clinical Oncology and previously presented at the 2024 ASCO Gastrointestinal Cancers Symposium (Abstract 603). Background.

Metastasis-Directed Radiation Therapy Plus Chemotherapy in Oligometastatic Pancreatic Cancer

The Food and Drug Administration (FDA) on Aug. 6 approved VORANIGO, the first targeted therapy for Grade 2 Isocitrate dehydrogenase (IDH) mutant glioma, a type of brain tumor. Available to patients as a once-daily pill, VORANIGO is the first significant treatment breakthrough in nearly 25 years for Grade 2 IDH mutant glioma, the drug’s maker Servier explained.

FDA approves Servier’s VORANIGO for certain brain tumors

Massachusetts State

SurvivorNet

A 31-year-old Massachusetts man living with a cancerous brain tumor is taking back control of his life after once losing the ability to walk and do other everyday tasks. Rohan Venkatesh found hope in a new and innovative approach to brain cancer treatment that drastically cuts down the time it takes to get a diagnosis from ten days to just two.

New Dramatically Quicker Method For Brain Cancer Diagnosis Helps Save Massachusetts Man– His Remarkable Recovery

Writers represent independent, third-party users who have joined our contributor program and self-verified their accounts. Writers are expected, like all users, to adhere to our Community Standards.

writer

J. Souza

A retired military officer who had been struggling with post-traumatic stress disorder (PTSD) tragically died after jumping from the world’s largest cruise ship last month, authorities confirmed.

Cruise Passenger Who Jumped from World's Largest Ship After Dispute Suffered with PTSD

Most cancer patients suffer poor mental health but few patients or clinicians are empowered to address it. There is an unintended collusion in the health system to deny the effect cancer can have on mental health. Managing mental health should be an integral part of the treatment and care for...

How to Treat Cancer in Its Entirety

Dr. Qin Rao, an ABMS board certified internal medicine physician specializing in gastroenterology and hepatology, spoke with Healthline about when people with ulcerative colitis (UC) might consider biologic therapy to manage their condition. What are biologics, and how do they work for ulcerative colitis?. Biologics are medications, usually given as...

An Expert Explains When to Consider Biologics for Ulcerative Colitis (UC)

New York Post

It’s a joint venture. 

Longevity enthusiasts are flying around the world and spending thousands of dollars to have stem cells injected into their ailing knees. 

Bryan Johnson, the businessman famed for spending a whopping $2 million a year to try and reverse the aging process. recently revealed that he flew to Physical Longevity in the Bahamas to undergo treatments in his knees, hips, and shoulders using mesenchymal stem cells (MSCs). 



Stems cell therapy has been used to treat a range of health conditions including leukemia and diabetes, but using another person’s cells to keep knees healthy is a relatively new...

Anti-aging enthusiasts are having stem cell injections in their knees — at more than $16K a pop

In 1972, Janet Rowley sat at her dining room table and cut tiny chromosomes from photographs she had taken in her laboratory. One by one, she snipped out the small figures her children teasingly called paper dolls. She then carefully laid them out in 23 matching pairs—and warned her kids not to sneeze.

Path to precision: Targeted cancer drugs go from table to trials to bedside

Interesting Engineering

Patients experienced a significant reduction in pain, improved their quality of life, and even showed signs of cartilage regrowth.

Stem cell shot reverses osteoarthritis, repairs knee cartilage, cuts pain by 58%

Two new studies have outlined major new findings in Parkinson's disease genetics. New research reported in the journal Brain has shown that genetic factors could be a far more significant influence on Parkinson's disease than thought. This study included 15,000 participants and was open to individuals who had received any type of Parkinson's diagnosis.

New Findings in Parkinson's Genetics may aid Diagnostics & Treatment

On June 14, 2024, the U.S. FDA approved AstraZeneca's Durvalumab (IMFINZI®) for primary advanced or recurrent endometrial cancer with mismatch repair deficiency. Endometrial cancer is the most prevalent gynecologic cancer, with an estimated 66,200 new U.S. cases in 2023. This approval demonstrates the effectiveness of immune checkpoint inhibitors, particularly targeting PD-L1 (CD274, B7-H1), a crucial factor in tumor immune evasion. Studying PD-L1 is essential for developing therapies that enhance immune responses to various cancers, potentially improving treatment success and patient outcomes.

FDA Accepted PD-L1 Inhibitor Durvalumab for the Treatment of Endometrial Cancer

Crexont kept symptoms at bay for an extra 30 minutes a day when compared with other Parkinson’s drugs. Amneal Pharmaceuticals Inc. announced yesterday the FDA approval for Parkinson’s drug Crexont (carbidopa and levodopa) via a news release on their website. This novel medication, formerly known as IPX203, combines two common drugs into one capsule.

FDA Approval Granted for Novel Parkinson’s Treatment

NewsBreak

Fasting-mimicking diet: A promising ally in cancer treatment

MILAN, Italy — In the ongoing battle against cancer, researchers are constantly seeking new weapons to add to our arsenal. Now, an intriguing approach is gaining...

Fasting-mimicking diet: A promising ally in cancer treatment

Comments / 0